Since the advent of high-throughput sequencing technologies, organised germline screening, independent of personal and family cancer history, has been frequently proposed. A critical prerequisite is knowledge of the expected carrier frequencies.
Drug-drug interaction (DDI) screening programmes aim to increase the safety of medication by issuing alerts based on the severity of DDIs. However, not all DDI alerts may be clinically relevant.
SMW is an international peer-reviewed medical journal, established in 1871.
Public Service Open Access is also known als Diamond or Platinum OA.
Newsletter for advertisers
Swiss Medical Weekly EMH Swiss Medical Publishers Ltd. Farnsburgerstrasse 8 CH-4132 Muttenz Tel. +41 (0)61 467 85 55 Fax +41 (0)61 467 85 56 e-mail: Editorial office
EMH MediaSchweizerische ÄrztezeitungSwiss Medical ForumPrimary and Hospital CareCardiovascular MedicineSwiss Archives of Neurology, Psychiatry and PsychotherapySynapseSwiss Medical Informatics